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Introduction 1
The primary cilium is a surface-exposed microtubule-based compartment that serves as an 2 organizing center for diverse signaling pathways [1] [2] [3] . Consistent with a central role for cilia in 3 signaling, mutations affecting cilia cause ciliopathies, a group of developmental disorders that 4
includes Joubert Syndrome, Meckel Syndrome (MKS), Nephronophthisis (NPHP), and Bardet-5
Biedl Syndrome (BBS). The defining symptoms of ciliopathies include skeletal malformations (e.g. 6 polydactyly), mental retardation, sensory defects (e.g. retinal degeneration), obesity, and kidney 7 cysts and are thought to arise from misregulation of ciliary signaling pathways. Over the past fifteen 8 years, advances in human genetics have led to the identification of over 70 ciliopathy disease 9 genes 4 . However, the molecular basis for many ciliopathy cases remains undiagnosed, suggesting 10 that additional ciliopathy genes have yet to be identified 5 . More broadly, many mechanistic aspects 11 of cilium assembly and function remain poorly understood, indicating a need for systematic 12 discovery and characterization of genes that enable ciliary signaling. 13
A key paradigm for ciliary signaling is the vertebrate Hedgehog (Hh) pathway, which 14 exhibits a strict dependence on primary cilia for signaling output 3 . Remarkably, all core 15 components of the Hh signaling machinery -from the receptor PTCH1 to the GLI protein 16 transcriptional effectors -dynamically localize to cilia during signal transduction. Nonetheless, the 17 precise role of cilia in Hh signaling remains elusive, and each successive step in signal transduction 18 is still incompletely understood 6 . Given the key roles of Hh signaling in embryonic development 19 and in cancers such as medulloblastoma and basal cell carcinoma 7, 8 , there is a pressing need to fill 20 the gaps in our understanding of Hh signal transduction. 21
Efforts to systematically identify genes needed for cilium assembly or Hh signaling have 22 been reported by a number of groups. However, these studies have relied on arrayed siRNA 23 libraries and exhibit the high rates of false positives and false negatives that are characteristic of 24 RNA interference (RNAi)-based screens [9] [10] [11] [12] . Recently, genome-wide screening using the 25 CRISPR/Cas9 system for gene disruption has emerged as a powerful tool for functional 26 genomics [13] [14] [15] [16] . CRISPR-based screens have already aided greatly in defining genes required for 27 proliferation of mammalian cells, revealing a core set of essential genes and cancer cell line-specific 28
vulnerabilities. However, the pooled screening format used in these studies requires a means to 29 select for/against or otherwise isolate cells exhibiting the desired phenotype, a technical 30 requirement that has significantly limited the scope of biological applications amenable to pooled 31 CRISPR-based screens. Indeed, most studies to date have searched for genes that either 1 intrinsically affect cell growth or that affect sensitivity to applied toxins, drugs, or microorganisms 17-2 24 . 3
Here, we engineered a Hh pathway-sensitive reporter to enable the systematic 4 identification of genes that participate in Hh signal transduction and primary cilium function. 5
Combining this reporter with a single guide RNA (sgRNA) library targeting the mouse genome, 6
we conducted a CRISPR-based screen that systematically identified ciliary components, Hh 7 signaling machinery, and ciliopathy genes with few false positives or false negatives. Our screen 8 also revealed many genes that had not previously been characterized or linked to ciliary signaling, 9
and we show here that these hits include new components of cilia and centrioles and novel 10 ciliopathy genes. 11
Results 1

Development of a Hh pathway transcriptional reporter for pooled screening 2
Pooled functional screening requires the ability to enrich or deplete mutant cells that exhibit 3 a desired phenotype from within a large population of cells. Because ciliary signaling is not 4
intrinsically linked to such a selectable/isolatable phenotype, we engineered a reporter construct 5 that converts Hh signaling into antibiotic resistance ( Fig. 1A-B ). This transcriptional reporter was 6 introduced into mouse NIH-3T3 fibroblasts, a widely used model cell line for Hh signaling and 7 cilium biology 25 . These cells were then further modified to express the Cas9 endonuclease fused to 8 BFP (3T3-[Shh-BlastR;Cas9] cells). 9
To confirm that our reporter cell line faithfully recapitulates ciliary Hh signaling and to test 10 its suitability for CRISPR-based mutagenesis, we introduced sgRNAs targeting regulators of the 11 canonical Hh pathway ( Supplementary Table 1 ). Smo, a key Hh pathway transducer, and Ift88, an 12 intraflagellar transport (IFT) complex subunit needed for cilium assembly, are required for Hh 13 signaling while GLI3 repressor dampens the Hh response and SUFU prevents Hh signaling in the 14 absence of ligand ( Fig. 1c, left) . As expected, sgRNAs targeting Smo or Ift88 severely reduced Sonic 15 Hedgehog N-terminal domain (ShhN)-induced blasticidin resistance, deleting Gli3 potentiated 16 blasticidin resistance in response to ShhN, and targeting Sufu gave rise to ligand-independent 17 blasticidin resistance (Fig. 1c, right) . The effects of these sgRNAs on blasticidin resistance were 18 paralleled by concordant changes in endogenous pathway outputs, including the induction of GLI1 19 and the shift from production of GLI3 repressor to GLI3 activator that normally occur upon 20 pathway activation ( Supplementary Fig. 1a ). 21
Having established a cell line that converts differences in ciliary Hh signaling into different 22 levels of blasticidin resistance, we next tested its suitability for pooled screening. The analysis of 23 our pooled screen is based on quantifying sgRNAs in blasticidin-selected and unselected cell pools 24 to identify sgRNAs that confer a selective advantage or disadvantage (Fig. 1d ). We therefore 
Genome-wide screening 1
We conducted our genome-wide screen using a newly developed sgRNA library targeting 2 the mouse genome 26 . Key features of this library are the use of 10 sgRNAs per gene and the 3 inclusion of >10,000 negative control sgRNAs that either do not have targets in the mouse genome 4 or that target "safe" sites with no predicted functional role. We introduced this library into 3T3-5 [Shh-BlastR;Cas9] cells via lentiviral transduction at low multiplicity of infection and maintained 6 sufficient cell numbers to ensure ~1000X coverage of the library (due to the large number of cells 7 required, we conducted the screen in four batches using subsets of the library; Supplementary Fig.  8 2a). After sgRNA transduction, cells were exposed to ShhN for 24 h to fully stimulate Hh signaling, 9 split into separate blastidicin-selected and unselected pools and then subjected to a second cycle of 10 signaling and selection before harvesting and sgRNA counting by deep sequencing (Fig. 1c ). Genes 11 affecting ciliary signaling were identified by comparing sequencing reads in the blastidicin-selected 12 versus unselected cell pools at the end of the experiment, while genes affecting proliferation were 13
identified by comparing the plasmid sgRNA library used for lentivirus production to the sgRNA 14 library after 15 days growth in the absence of blasticidin. For statistical analysis, a maximum 15 likelihood method termed casTLE 27 was used to determine a P value for each gene from the 16 changes in abundance of the corresponding sgRNAs. In addition, the casTLE method also 17 estimates an effect size corresponding to the apparent strength of the phenotype caused by 18 knockout of a given gene. 19
20
Assessment of screen performance 21
To evaluate the quality of our screen, we first assessed its performance in detecting genes 22 affecting growth. This readout is independent of our reporter-based selection strategy and enables 23 comparisons to other growth-based screens. It also provides an opportunity to evaluate the 24 performance of our sgRNA library, as this study represents its first use in a genome-wide screen. 25
Using reference positive and negative essential gene sets 28 , we found that our screen detected 26 growth-affecting genes with few false positives or false negatives, identifying >90% of essential 27 genes with a 5% false discovery rate (FDR) ( Supplementary Fig. 2b and Supplementary Tables 2-28 3). This performance is comparable to that seen recently with two other libraries 19,21 . 29 We next evaluated the ability of the blasticidin-based screen to identify genes known to 30 participate in ciliary Hh signaling. Initial inspection of screen results for Smo, Ift88, Gli1, Gli3, and 31
Sufu revealed several sgRNAs targeting each gene that were depleted or enriched as expected upon 1 blasticidin selection ( Fig. 2a ). Virtually all known Hh signaling components were among the top 2 hits, including positive regulators Smo, Grk2, Kif7, Prkar1a, Gli1, and Gli2 and negative regulators 3 Ptch1, Adcy6, Gsk3b, Sufu, and Gli3 ( Fig. 2b and Supplementary Table 4 ). 4
In addition to identifying Hh pathway genes, our screen recovered many hits required for 5 the assembly and function of primary cilia. Remarkably, these hits encompass nearly all functional 6 and structural elements of cilia, highlighting the diverse features of cilia needed for effective 7 signaling ( Fig. 2c ). For example, several hits encode components of the basal body that nucleates 8 the cilium, the transition fibers that anchor the basal body to the cell surface, the transition zone 9 that gates protein entry into the cilium, the ciliary motors that mediate intraciliary transport, and 10 the IFT complexes that traffic ciliary cargos ( Fig. 2c and Supplementary Table 4 ). The detection 11 of nearly all IFT-A and IFT-B genes as hits also underscores the low rate of false negatives. 12
We observed no apparent correlation between growth and signaling phenotypes, indicating 13 that our antibiotic selection strategy is not biased by general effects on proliferation (Supplementary 14 Fig. 2c ). However, because low sgRNA counts were commonly obtained for genes with the 15 strongest growth defects, the estimated signaling phenotypes for these genes may be less reliable 16 and were considered separately. In total, we obtained 472 hits at a 10% FDR and 969 hits at a 17 20% FDR, and the majority of these hits led to decreased signaling rather than increased signaling 18 ( Fig. 2c ). Gene ontology (GO) term analysis using DAVID 29 revealed that the top 472 hit genes 19
were significantly enriched for many expected functional categories (e.g. cilium morphogenesis, P 20 < 1x10 -60 ; Smoothened signaling pathway, P < 1x10 -31 ) as well as some novel categories, indicating 21 new avenues for investigation ( Fig. 2d and Supplementary Table 5 ). In some cases, corroborating 22
reports support these new connections: for example, mouse mutants for two hit genes that mediate 23 diphthamide modification exhibit Hh pathway-related phenotypes such as polydactyly 30, 31 . DPH1 24 mutations have also been shown to cause a poorly characterized syndrome with several ciliopathy-25 like features including cerebellar vermis hypoplasia, craniofacial malformations, and cardiac 26 defects 32 . Other unexpected gene categories, such as endosome-to-lysosome transport or the Ras 27 signaling pathway, will require further investigation. 28
We next sought to use reference sets of expected hit and non-hit genes to quantitatively 29 assess screen performance. To this end, we curated a set of ciliogenesis reference genes 9 to generate 30 a list of 130 expected hits ( Supplementary Table 3 ). For expected non-hits, we used 1386 olfactory 31 and vomeronasal receptor genes, as they are likely not expressed in cultured fibroblasts. Using 1 these reference gene sets, we calculated precision-recall and receiver operating characteristic 2 (ROC) curves ( Fig. 3a ) from the P values generated by casTLE. Both performance metrics show a 3 high area under the curve (0.802 for precision-recall, 0.892 for ROC), demonstrating that our 4 screen detects hits with high sensitivity and precision ( Fig. 3a) . 5
As a second means of evaluation, we compared our ability to detect expected hit genes to 6 that of three related screens. These studies used arrayed siRNA-based screening to study either Hh 7 signaling using a luciferase reporter 11 or ciliogenesis using microscopy-based measures of ciliary 8 markers 9, 10 . While there are notable differences among the screens (e.g. Roosing et al. incorporated 9 data from other sources such as gene expression to score hits 9 ), they each defined a number of hit 10 genes similar to (or greater than) our screen, thus making it straightforward to compare 11 performance. Overall, we detected the vast majority of expected hits across functional categories 12 ranging from Hh pathway components to ciliopathy genes. Furthermore, even though our screen 13 was focused on Hh signaling, we detected a greater fraction of ciliary hits than the ciliogenesis 14 screens across categories including IFT subunits, ciliary motors, and nearly all classes of ciliopathy 15 genes ( Fig. 3b -c, Supplementary Fig. 3a and Supplementary Table 4 ). One exception however is 16 the group of genes mutated in NPHP, where we found few hit genes (particularly when analyzing 17 genes mutated exclusively in NPHP). While the basis of this finding warrants further study, it raises 18 the possibility that NPHP pathophysiology may be distinct from that of other ciliopathies. 19
As a final assessment of our screening platform, we evaluated reproducibility across 20 replicate screens. We observed high concordance among hits for the 95 genes that were measured 21 in two different batches of the screen ( Supplementary Fig. 3b ), with 50 of 54 screen hits also scoring 22
as hits in the second batch. Similarly, strong overlap in hits was found for 263 genes that were 23 screened using two similar but distinct means to initiate Hh signaling: addition of PTCH1 ligand 24 (ShhN) or SMO agonist (SAG) ( Supplementary Fig. 3c ). This reproducibility makes it possible to 25 directly compare screens and pinpoint genes acting at specific steps in Hh signal transduction. For 26 example, Gas1 was a hit in the ShhN screen but not in the SAG screen, a result in agreement with 27 GAS1's known function as a Shh co-receptor 33, 34 . Overall, our results indicate that combining 28 CRISPR-based screening with a pathway-specific transcriptional reporter is a powerful strategy 29 for functional genomics. 30
31
Identification of new ciliary components 1
The effectiveness of our screen in identifying genes known to participate in cilium function 2 corroborates the essentiality of this organelle for vertebrate Hh signaling, and our success in 3 identifying the known Hh signal transduction machinery suggests that novel Hh pathway 4 components will be found among the many hits. Given that there are likely many more cilium-5 related genes than core Hh pathway components, we set out to characterize the roles of six hit 6 genes in cilium biology as a way to further establish the value of our screen. 7
We first focused on Fam92a and Ttc23 because their gene products contain domains 8 associated with membrane trafficking. For Fam92a, we confirmed our pooled screen results in cells 9
transduced with individually cloned sgRNAs, finding that Fam92a knockout caused a strong defect 10 in inducible blasticidin resistance ( Supplementary Fig. 4a ). This defect was also seen for induction 11 of luciferase from a GLI binding site reporter and could be rescued by re-introduction of sgRNA-12
resistant Fam92a (Fig. 4a ), indicating that the phenotype is both specific and independent of the 13 blasticidin-based readout. Notably, ciliogenesis was also severely reduced in Fam92a knockout cell 14 pools ( Fig. 4b ). To gain further insight into Fam92a function, we identified FAM92A-associated 15 proteins using a cell line expressing FAM92A-LAP (localization and affinity purification tag 16 consisting of S-tag-HRV3C-GFP). Affinity purification of FAM92-LAP specifically recovered the 17 known transition zone components CBY1 and DZIP1L ( Fig. 4c and Supplementary Table 6 ) 35-37 . 18 Consistent with this finding, we observed prominent FAM92A localization at the transition zone 19 using both an antibody whose specificity we validated in knockout cells ( Supplementary Fig. 4b -c) 20 and the FAM92A-LAP cell line ( Fig. 4d ). While this work was in progress, another group 21 independently identified FAM92A as a transition zone protein contributing to ciliogenesis, 22 corroborating our studies 38 . 23 To characterize the TPR domain-containing protein TTC23, we analyzed TTC23-24
interacting proteins by affinity purification and mass spectrometry. Notably, the most prominent 25 TTC23-associated proteins were IQCE and EFCAB7, which represent the non-transmembrane 26 components of the Ellis-van Creveld (EvC) zone. The EvC zone is a proximal region of the cilium 27 that is important for Hh signaling but dispensable for cilium assembly 39, 40 (Fig. 4e and 28 Supplementary Table 6 ). Of the four proteins -EVC, EVC2, IQCE, and EFCAB7-that are 29 known to localize to the EvC zone, EVC and EVC2 are also mutated in the ciliopathy Ellis-van 30
Creveld syndrome 41 . Consistent with the biochemical interactions we identified, TTC23-LAP co-31 localized with EVC and IQCE at the EvC zone ( Fig. 4f and Supplementary Fig. 4d ). To assess 1 TTC23 function, we examined Ttc23 knockout cells, which showed a moderate reduction in 2 inducible blasticidin resistance but no defect in cilium assembly ( Supplementary Fig. 4a ,e). Ttc23 3 knockout cells also showed reduced localization of IQCE and EVC to the EvC zone ( Fig. 4g and 4 Supplementary Fig. 4f -g); conversely, Iqce RNAi led to a strong decrease in TTC23-LAP 5 localization to the EvC zone ( Fig. 4h ). Together these results establish TTC23 as a novel EvC zone 6 component that participates in Hh signaling. 7 8
Identification of novel disease genes 9
Because the vast majority of ciliopathy genes were hits in the screen, we asked whether 10 uncharacterized hit genes may be mutated in ciliopathies of previously unknown etiology. We first 11
examined Txndc15, a screen hit that encodes a thioredoxin domain-containing transmembrane 12 protein of unknown function. Notably, a previous analysis of MKS patients identified a family with 13 a TXNDC15 mutation 42 . However, other candidate genes could not be ruled out, and an EXOC4 14 variant was favored as the causative mutation. To investigate whether loss of TXNDC15 might 15 cause a ciliopathy, we analyzed Txndc15 knockout cells using the luciferase-based reporter assay, 16
finding a clear defect in Hh signaling. Furthermore, introduction of wildtype Txndc15 rescued this 17 defect, whereas cDNA encoding the mutant allele found in MKS patients behaved like a null allele 18 ( Fig. 5a ). We also found that cilia in Txndc15 knockout cells exhibited increased variability in length 19
and decreased levels of the ciliary GTPase ARL13B ( Fig. 5b and Supplementary Fig. 5a-b ). Thus, 20
TXNDC15 likely represents a novel MKS gene, and our screening system can provide a 21 straightforward means to functionally test candidate mutations identified in patients. Consistent 22 with our findings, a very recent follow-up study has identified additional MKS families with 23 TXNDC15 mutations 43 . 24 Similarly, the finding that Armc9 is a hit in our screen raises the possibility that it is a diagnosis of Bardet-Biedl syndrome 45 . We found that cilia from Armc9 -/cells were short and 28 exhibited reduced levels of acetylated and polyglutamylated tubulin ( Fig. 5c and Supplementary 29 Fig. 5c ). Furthermore, ARMC9-3xFLAG prominently localized to the proximal region of cilia 30 when stably expressed in IMCD3 cells. Notably, stimulation of Hh signaling led to relocalization 31 of ARMC9 towards the ciliary tip within 6 hr before a gradual return to its original proximally 1 biased localization, suggesting that ARMC9 may become ectocytosed at later time points 46 (Fig.  2 5d-e). Furthermore, signaling-induced tip accumulation of GLI2 and GLI3 was reduced in Armc9 3 mutant cells ( Fig. 5f and Supplementary Fig. 5d ) but SMO translocation to cilia was intact 4 ( Supplementary Fig. 5e ), suggesting that ARMC9 specifically participates in the trafficking and/or 5 retention of GLI proteins at the ciliary tip. Collectively, these findings demonstrate that ARMC9 6 is a ciliary signaling factor and suggest that ARMC9 is a novel ciliopathy gene. 7
The observation that ARMC9-(and DPH1-) based syndromes likely represent unrecognized 8 ciliopathies led us to ask whether our screen could help classify other genetic disorders as 9
ciliopathies. Consistent with this possibility, the peptidyl-prolyl isomerase Cwc27 was a hit in our 10 screen and was recently identified as a retinitis pigmentosa (RP) gene 47 . Although this syndrome 11
was not recognized as a ciliopathy, the spectrum of CWC27 pathologies reported includes 12 canonical ciliopathy symptoms (craniofacial abnormalities, short stature, brachydactyly, and 13 developmental delay), and we therefore suggest that CWC27-associated disease is a ciliopathy. 14 Similarly, mutations in genes encoding the INTS1 and INTS8 subunits of the Integrator complex 15
were recently described in individuals with a neurodevelopmental disorder with additional facial 16 and skeletal malformations commonly seen in ciliopathies 48 . As the Integrator genes Ints6 and 17
Ints10 are hits in our screen, disorders due to defects in Integrator complex function may also stem 18 from altered ciliary signaling. 19
These cases of individual disorders that can now be classified as likely ciliopathies led us to 20 ask whether systematic efforts to map disease genes might reveal broader commonalities with our 21 screen hits. Strikingly, we found that screen hits ANKRD11, CDK13, CHD4, FOXP1, KMT2D, and 22 PRKD1 were all recently identified in a large-scale exome sequencing study of patients with 23 congenital heart defects (CHD) 49 . The significant overlap in these two unbiased datasets (P = 6.11 24
x 10 -4 ) provides compelling evidence that defective ciliary signaling may be a prevalent cause of 25
CHDs. Moreover, mutations in these genes appear to cause bona fide ciliopathies, as patients also 26 exhibit ciliopathy symptoms including craniofacial abnormalities and developmental delay 27 (ANKRD11, CDK13, CHD4, FOXP1, KMT2D, PRKD1), dysgenesis of the corpus callosum (CDK13), 28 polydactyly (CHD4), obesity (ANKRD11), and craniofacial malformations (ANKRD11 and 29 KMT2D) 4, 49, 50 (Fig. 5g) . A link between primary cilia and heart defects was reported in a recent 12 forward genetic study in mice 51 , and our screen now extends this finding to include several human 1 disease cases. Unexpectedly, our screen hits encode not only canonical ciliary proteins but also centriolar 5
proteins not previously linked to ciliary Hh signaling. Given the roles of hits such as CEP19, 6 CEP44, CEP120, and CEP295 at centrioles, we considered whether other hits might also have 7 centriolar functions. Indeed, the uncharacterized hit 1600002H07Rik (human C16orf59) localized 8
to centrioles when stably expressed in IMCD3 cells ( Fig. 6a ). We performed affinity purifications 9
and found that 1600002H07Rik-LAP co-purified with the uncharacterized protein 10 4930427A07Rik (human C14orf80) and the distant α/β-tubulin relatives ε-tubulin (TUBE1) and 11 δ-tubulin (TUBD1) ( Fig. 6b ). All four of these gene products are also among the top-scoring hits in 12 our screen, and ε-tubulin and δ-tubulin have previously been linked to centriole assembly and 13 maintenance [52] [53] [54] [55] [56] . We therefore propose to name 4930427A07Rik/C14orf80 and 14 1600002H07Rik/C16orf59 as Ted1 and Ted2, respectively, for their functional link and biochemical 15 association with tubulins epsilon and delta. 16
Our mass spectrometry analysis of TED2-associated proteins revealed approximately 17 stoichiometric amounts of TED1, TED2, ε-tubulin, and δ-tubulin, as seen by comparison of the 18 normalized spectral abundance factors ( Fig. 6b and Supplementary Table 6 ). We also noted lower 19 amounts of co-purifying α/β-tubulin and CENPJ/CPAP, a centriolar regulator of microtubule 20 dynamics 57-59 . To corroborate these mass spectrometry analyses, we confirmed co-purification of 21 TUBD1 and TUBE1 by Western blot, readily detecting these proteins in our TED2-LAP 22 purification but not in a negative control purification ( Supplementary Fig. 6a ). We also tested for 23 an interaction between TED1 and TED2 by co-transfection and co-immunoprecipitation. Not 24 only did we detect a specific interaction between these proteins, we found that TED1 and TED2 25 mutually stabilize their expression levels, leading to notably higher expression when expressed 26 together versus individually ( Fig. 6c ). 27
To functionally characterize Ted1 and Ted2, we first examined knockout cells generated 28 using two sgRNAs targeting each gene. Strikingly, we found that Ted1 and Ted2 knockout cell pools 29
were almost completely devoid of centrioles, as assessed by staining with antibodies to centrin, 30 ninein, polyglutamylated tubulin or γ-tubulin ( Fig. 7a-b ). Congruently, mutant cells also lacked 31 cilia ( Fig. 7a ) and had strong defects in Hh pathway reporter induction and GLI protein regulation 1 ( Supplementary Fig. 6b -c). We also noted that Ted1 and Ted2 mutants exhibited a mild growth 2 defect ( Supplementary Table 3 ), which is consistent with recent evidence that NIH-3T3 cells 3 lacking centrioles can continue to proliferate, albeit at a reduced rate 60 . By contrast, in other cell 4 types, a p53-dependent arrest prevents proliferation in the absence of centrioles. These 5 observations prompted us to investigate whether loss of Ted1 or Ted2 has varying effects on 6 proliferation across different cell types, and whether such phenotypic variability could enable 7 predictive identification of genes with similar function. We therefore examined a recently published 8 collection of CRISPR-based growth screens conducted in 33 different human cell lines and used 9 hierarchical clustering to group genes based on the similarity of their cell type-specific growth 10 phenotypes 61 . Strikingly, this unbiased approach placed Ted1, Ted2, and Tube1 in a single cluster 11 ( Fig. 7b and Supplementary Table 7 ), suggesting that they have a highly similar function in 12 addition to encoding components of a shared protein complex. We note that TUBD1 did not co-13
cluster but was likely not effectively targeted by this sgRNA library. 14 To better understand the basis for centriole loss in Ted1 and Ted2 mutants, we examined 15 centrioles in cells at different stages of the cell cycle. Surprisingly, while mutant cells typically had 16 zero or one centriole in interphase, nearly all mitotic cells had excess centrioles (more than four), 17
suggestive of de novo centriole formation before mitotic entry ( Fig. 7c-d and Supplementary Fig. 6d ). 18
By contrast, cells exiting mitosis more closely resembled interphase cells, again showing 19
significantly decreased centriole numbers compared to negative control sgRNA-expressing cells 20 ( Fig. 7d ). Taken together, these observations suggest that Ted1 and Ted2 are dispensable for 21 centriole biogenesis but required for centriole stability, with newly generated centrioles rapidly lost 22
as cells exit mitosis. 23
While the biochemical activities of ε-tubulin and δ-tubulin remain elusive, very recently 24 TUBE1and TUBD1-deficient human RPE1 cells were found to frequently lack centrioles and 25 undergo cycles of de novo centriole biogenesis followed by disappearance of these centriole-like 26 structures during progression through the cell cycle (J. Wang and T. Stearns, personal 27 communication). This phenotype echoes our findings in Ted1 and Ted2 mutant cells, and together 28 with our biochemical findings indicates that the TED complex is required for centriole stability. 29
Discussion 1
Here we present a new functional screening platform that pairs a pathway-specific 2 selectable reporter with genome-wide CRISPR-based gene disruption. Applying these 3 technologies to systematically investigate cilium-dependent Hh signaling, we obtain a 4 comprehensive portrait of cilium biology that identifies hit genes with high sensitivity and 5 specificity, surpassing the performance seen in related siRNA-based arrayed screens. As a result, 6 we identify many novel hit genes, and we show that a number of previously uncharacterized gene 7
products have diverse functions in cilium assembly and ciliary signaling. Several factors likely contributed to the quality of our screen, including the pooled 11 screening format, the use of CRISPR for gene disruption, and a newly designed sgRNA library. 12
Given the strong influence of cell confluence on cilium assembly and Hh signaling, the 13 homogeneous growth conditions afforded by pooled screening were likely a major advantage. In 14 an arrayed format, perturbations causing growth defects can indirectly affect ciliogenesis by 15 decreasing cell density, thus generating false positives that need to be filtered out 10 . Pooled screens 16 achieve confluence regardless of genotype, and thus we can successfully identify hits that have 17 moderate proliferation defects, including the four components of the TED complex. 18
Another key feature of our screen is the use of CRISPR-based gene disruption. The strong 19 phenotypes produced by CRISPR/Cas9 likely made it possible to detect hit genes in cases where 20 partial knockdown by RNAi or CRISPR interference (CRISPRi) might have failed to produce a 21 detectable phenotype. A potential caveat of our approach is a decreased ability to detect hits among 22 genes that are strictly required for cell viability. However, because ciliary signaling is dispensable 23 for growth of cultured cells, this issue likely had a limited impact on our screen. It is also important 24 to note that the allelic series achievable with RNAi and CRISPRi may be preferable when 25
screening for phenotypic modifiers, as in chemical genetic or genetic interaction analyses. 26
The strong performance of CRISPR-based screening may also be attributable to our use 27 of an sgRNA library comprised of many highly active sgRNAs with few off-target effects. High on-28 target activity is especially important for detecting hits in dropout-based screens (in which hits 29 become depleted) and was achieved by using 10 sgRNAs per gene and by optimizing the stability 30 of Cas9 expression. A second benefit of using 10 sgRNAs per gene is the increased statistical power 31 achieved when multiple effective sgRNAs are found targeting a single gene. Indeed, for hit genes 1 such as Dync2h1, Tmem107, Ift80, B9d1, and Grk2, at least 7 out of 10 sgRNAs were depleted more 2 than 4-fold (and up to 45-fold), leading to high statistical confidence. While other genes may not 3 have been targeted as efficiently, the use of 10 elements per gene strongly increases the statistical 4 power of hit gene detection. 5
A final important feature of our screening platform is that it can readily be extended to 6 other biological processes. To date, most CRISPR-based screens have been limited to situations 7
where the phenotype of interest directly affects cell viability, such as defining factors affecting cell 8 proliferation or resistance to toxins, drugs, or microorganisms. By using a reporter-based selectable 9 marker, our approach allows powerful screening tools to be applied to virtually any process with a 10 well-defined transcriptional response. 11
12
New insights into cilium biology, Hh signaling, and ciliopathies 13
The combined benefits of our pooled CRISPR-based screening approach enabled us to 14 generate a rich dataset that we anticipate will be a lasting resource in the field, both for dissecting 15 the basic mechanisms of ciliary signaling and also for defining new ciliopathy genes and potential 16 therapeutic targets in Hh-driven cancers. While prior siRNA-based screens have contributed to 17 our understanding of cilium function and Hh signaling, many of these datasets suffer from false 18 positives or false negatives that limit their utility. In addition, most screens focused on cilium 19
assembly rather than Hh signaling and thus do not identify Hh pathway components. Roosing et 20 al. 9 improved their ciliogenesis screen results by using known positive and negative gene sets to 21 help classify hits and by incorporating gene expression datasets in addition to their microscopy-22 based screen data. Our screening approach achieved high performance without dependence on 23 other data sources, which may not always be available, or on a priori definition of hits, which could 24 bias discovery of new hit classes. Our screens are also highly reproducible, thereby enabling 25 comparative screening approaches that will be instrumental in uncovering novel factors acting at 26 specific steps in Hh signaling, in particular the regulation of SMO by PTCH1, a poorly understood 27 yet critical aspect of Hh signaling. 28
The practical value of our screen is demonstrated by the discovery of new genes that 29 participate in ciliary signaling and new candidate ciliopathy genes. While the precise roles of 30 FAM92A at the transition zone and TTC23 at the EvC zone will require further study, our screen 31 demonstrates that new components remain to be identified even for these well-studied ciliary 1 structures. Similarly, our analyses of TXNDC15, ARMC9, CWC27, DPH1, INTS6, INTS10,  2 ANKRD11, CDK13, CHD4, FOXP1, PRKD1, and KTM2D illustrate that screen hits can help to 3 identify a ciliopathy-causing gene from a short list of variants, as is frequently the case in modern 4 genome sequencing of small pedigrees, and to classify new genetic syndromes as disorders of ciliary 5 signaling. Indeed, with the exception of TXNDC15, all of the aforementioned genes had been 6 previously linked to disease states (e.g. KMT2D and Kabuki Syndrome, OMIM 147920; ANKRD11 7 and KBG Syndrome, OMIM 148050; DPH1 and Loucks-Innes Syndrome, OMIM 616901) 8 without a potential role for cilia described. Among the syndromes caused by mutations in these 9 genes, it is striking that the most prevalent feature is CHD. Our screen thus provides unbiased 10 evidence that several CHD cases are bona fide ciliopathies, thereby building upon similar 11 connections observed in mice and motivating future investigations by human geneticists and 12 developmental biologists. 13
It is also noteworthy that our screen hits include the vast majority of known ciliopathy genes 14
but not those primarily linked to kidney pathology (with or without laterality defects). In particular, 15
the NPHP genes that are associated with the Inversin compartment (INVS, NPHP3, ANKS6, NEK8) 16 and the polycystic kidney disease genes PKD1, PKD2, and PKHD1 are all non-hits. This finding 17
suggests that these renal diseases are mechanistically distinct from other ciliopathies, likely acting 18 independently of Hh signaling and possibly even involving pathomechanisms independent of 19 cilia 62 . By capturing a comprehensive and unbiased picture of cilium-based signaling, our screen 20 refines the classification of ciliopathies. More broadly, as genome sequencing reveals disease-21 associated variants at ever-growing rates, genome-wide functional studies such as that presented 22
here will become a powerful resource to distinguish disease-causing mutations from innocuous 23 variants 63 and to gain insight into underlying disease mechanisms. 24
Our screen also identifies hit genes with highly diverse roles in cilium function and Hh 25 signaling, including several genes that participate in centriole biology. For hits Ted1, Ted2, ε-tubulin 26 and δ-tubulin, we found that these four genes act in concert to ensure centriole stability, as 27 evidenced by the association of their gene products in a complex. This complex appears to be a 28 stoichiometric tetramer and demonstrates that ε-and δ-tubulin directly associate. While the 29 structural basis for this interaction awaits further study, it is tempting to speculate that ε-and δ-30 tubulin may form a heterodimer analogous to α/β-tubulin. In addition to the physical association 31 of TED complex components, deficiency for these genes leads to a remarkably similar pattern of 1 growth phenotypes across cell lines. This observation provides further evidence for a shared 2 function and complements recent work demonstrating the precise functional predictions made 3 possible by CRISPR-based growth profiling 19 . 4
Similar to the aforementioned pattern of cell-type-specific growth phenotypes, Turk et al. 64 5 recently observed a phylogenetic pattern in which the presence or absence of ε-tubulin in a given 6 species predicts whether δ-or ζ-tubulin is also present. The evolutionary co-occurrence of these 7 centriolar tubulins prompted us to ask whether Ted1 and Ted2 also share a similar phylogenetic 8 distribution. We found Ted1 and Ted2 homologs in annelids and sea urchin and Ted1 homologs in 9
evolutionarily distant species such as Paramecium tetraurelia and Tetrahymena thermophila 10 ( Supplementary Fig. 7a ). Consistent with a conserved functional relationship among TED complex 11 components, all of these species also have ε-, δ-and/or ζ-tubulins; conversely, we did not detect 12
Ted1 or Ted2 homologs in any species lacking ε-, δ-and ζ-tubulins. The scope of this analysis was 13 limited by the more rapid divergence seen for Ted1 and Ted2 sequences than for ε-, δ-and ζ-14 tubulins ( Supplementary Fig. 7b ), but this phylogenetic distribution further supports a shared 15
function and echoes what is seen for γ-tubulin and subunits of the γ-tubulin ring complex. 16
Notably, studies across diverse species have implicated ε-and δ-tubulins in stabilizing 17 centriolar microtubules. For example, defects in Paramecium or Tetrahymena ε-tubulin or in 18
Chlamydomonas reinhardtii δ-tubulin all lead to centrioles lacking the C and/or B tubules of the 19 centriolar triplet microtubules 53, 55, 56 . Consistent with these reports, we find that Ted1 and Ted2 20 knockout cells are markedly deficient in centriole maintenance. We speculate that the centriolar 21 structures formed in Ted1/2-deficient cells are structurally unstable and degenerate during mitotic 22 exit at the time when pericentriolar material (PCM) is stripped from the centrosome and duplicated 23 pairs of centrioles become disengaged. Since removal of the PCM has been recently shown to cause 24 centriolar instability in fly spermatocytes 65 , we consider post-mitotic PCM removal may be a key 25 event contributing to centriole loss in Ted mutants. CENPJ may act together with the TED complex 26
to ensure centriole stability, as CENPJ was found in our TED2 purifications and a mutation in 27
Cenpj/Sas-4 was recently shown to lead to loss of triplet microtubules in Drosophila spermatocytes 66 . 28
Lastly, given that several centriolar genes including CENPJ cause microcephaly when mutated 67, 68 , 29 TED complex components are potential candidate genes for this neurodevelopmental disorder. 30
In summary, we have developed a functional screening platform that provides a valuable 1 resource for the investigation of long-standing questions in Hh signaling and in the biology of 2 primary cilia. By applying and extending these tools, it may now be possible to systematically define 3 vulnerabilities in Hh pathway-driven cancers, to search for suppressors of ciliopathies that may 4 inform treatment, and to identify modifiers of Hh pathway-inhibiting chemotherapeutics. 5
Integrating this functional genomic approach with complementary insights from proteomics and 6 human genetics promises a rich toolkit for understanding ciliary signaling in health and disease. 7
More broadly, the approach described here makes CRISPR-based screening possible for 8 essentially any biological process with a defined transcriptional output. 9 1
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EXPERIMENTAL MODELS AND SUBJECT DETAILS 7
Cell lines and cell culture 8 NIH-3T3 and HEK293T cells were grown in high glucose DMEM supplemented with 9 10% fetal bovine serum (FBS), 2 mM glutamine, 1 mM sodium pyruvate, 10 U/ml penicillin and 10 10 µg/ml streptomycin. Light-II NIH-3T3 cells 25 were grown in the same medium except with 11 10% bovine calf serum (BCS), and IMCD3 cells were grown in DMEM/F12 medium with the 12 same FBS, glutamine, penicillin and streptomycin additives. Serum starvation was done with the 13 same media but with 0.5% FBS for NIH-3T3 cells, 0.5% BCS for Light-II NIH-3T3 cells, and 14 0.2% FBS for IMCD3 cells. Cells were passaged using 0.05% trypsin-EDTA. IMCD3 FlpIn cells 15
were provided by Peter Jackson. NIH-3T3 cells were obtained from ATCC. HEK239T-EcR-16 ShhN cells were provided by Philip Beachy. Cells were confirmed to be mycoplasma free by regular 17 testing with the MycoAlert system (Lonza). 18
19
METHOD DETAILS 20
DNA cloning 21
Individual sgRNAs were cloned by ligating annealed oligonucleotides into pMCB306 or 22 pMCB320 digested with BstXI and Bpu1102I (Fermentas FastDigest enzymes, Thermo Fisher). 23
Ligated products were transformed into Mach1-T1 competent cells (Thermo Fisher) and recovered 24 plasmids were verified by sequencing. 25
Cilia-focused sgRNA libraries were cloned from oligonucleotide pools (Agilent) as 26 described 26 . Briefly, oligonucleotides were amplified using primer sequences common to each sub-27 library, digested with BstXI and Bpu1102I, and ligated into pMCB320, followed by transformation 28
into Endura competent cells (Lucigen). DNA was isolated from collected bacterial colonies using a 29
Plasmid Plus Giga kit (Qiagen). 30
22
Individual cDNAs encoding genes of interest were amplified from mouse cDNA or 1 commercially available sources (Dharmacon) and cloned into Gateway Entry vectors either via BP 2 clonase-mediated recombination (Thermo Fisher) or using isothermal assembly. Mutations to 3 introduce resistance to sgRNA-mediated cleavage were introduced by isothermal assembly. Cells were transduced by addition of viral supernatants diluted to an appropriate titer in 25 growth medium containing 4 µg/ml polybrene (Sigma Aldrich). Following 24 h incubation at 26
37°C, virus-containing medium was removed; after an additional 24 h, cells were passaged and, 27
where appropriate, selection for transduced cells was commenced by addition of 2.0 µg/ml 28 puromycin (Invivogen). Multiplicity of infection was determined by flow cytometry-based analysis 29 of fluorescent marker expression. 30
ShhN production and titering 1
The HEK239T-EcR-ShhN cell line was used to produce ShhN-containing conditioned 2 medium. Cells were grown to 80% confluence, medium changed to DMEM with 2% FBS, 3 followed by collection of conditioned medium after 48 h and filtration through a Steritop 0.22 µm 4 filter device (EMD Millipore). The titer of ShhN was determined using NIH-3T3 Light-II 8xGli 5 luciferase reporter cells (see Luciferase reporter assays), and a concentration approximately two-fold 6 over the minimum dilution needed for full luciferase induction was used for further experiments. to introduce Pgk-Cas9-BFP, followed by three rounds of sorting the pool of transduced cells for 20 high-level BFP expression. Notably, we found that other promoters either failed to stably express 21
Cas9 after weeks of passaging or produced an excessive level of Cas9 that led to toxicity (data not 22 shown). 23
Stable cell lines for affinity purification and localization studies were generated using the 24
FlpIn system (Life Technologies) that relies on FRT-mediated recombination into a single FRT 25
site present in IMCD3 FlpIn cells. Plasmids encoding genes of interest in the pEF5B/FRT-DEST-26
LAP (or 3xFLAG) vector were transfected into IMCD3 FlpIn cells together with pOG44 Flp 27
recombinase (Life Technologies) using X-tremegene 9 (Roche). Recombined cells pools were 28 obtained following selection with blasticidin (Sigma Aldrich) and were used for further analysis. 29
3T3-[Shh-BlastR;Cas9] cells were seeded for signaling and grown to confluence. Growth 1 medium was then replaced with serum starvation medium with or without pathway agonist (ShhN 2 conditioned medium at appropriate dilution or SAG (synthesized as described 70, 71 ) at 250 nM). 3
After 24 h, cells were passaged at approximately 1:6 dilution to fresh medium with 10% FBS, 4 allowed to adhere for 5 h, and then subjected to blasticidin (blasticidin S hydrochloride, Sigma 5
Aldrich) selection at concentrations ranging from 0.5 to 20 µg/ml for 4 d. Relative viability was 6 determined using the CellTiter-Blue fluorescence-based assay (Promega), and fluorescence read on 7 a SpectraMax Paradigm (Molecular Devices) or Infinite M1000 (Tecan) plate reader. 8 9
Genome-wide screening 10
Genome-wide screening was conducted in four batches of ~45,000-70,000 sgRNAs 26 . For 11 each batch, lentivirus was produced and titered as described above. 3T3-[Shh-BlastR;Cas9] cells 12
were grown in 15 cm plates and transduced at a multiplicity of infection of ~0.3 in sufficient 13 numbers such that there was a ~500:1 ratio of transduced cells to sgRNA library elements. Cells 14
were selected with puromycin for 5 d, grown for 3 d without puromycin, and then plated for 15 signaling, maintaining a ~1,000:1 ratio of cells to sgRNAs for these and all subsequent steps. After 16 cells reached confluence, signaling was initiated by addition of serum starvation medium 17 containing ShhN. After 24 h, cells were passaged, allowed to adhere, and then subjected to 18 blasticidin selection for 4 d at 5 µg/ml, a concentration we found sufficient to achieve strong 19 enrichment/depletion of hits without causing sgRNA library bottlenecks due to excess cell death. 20
After passaging cells to blasticidin-free medium, a 'T1' sample was harvested (1000-fold more cells 21 than sgRNAs) and remaining cells were passaged once more before seeding for a second round of 22 signaling and selection. The final 'T2' cell sample was collected following 4 d blasticidin selection 23
and one additional passage in the absence of blasticidin. Unselected control cells were also 24 propagated through the entire experiment and harvested at equivalent timepoints. 25
Screens using the cilia/Hh pathway-focused library were conducted as above except that 26 a variant blasticidin reporter cell line was used in which Cas9-BFP was expressed using the 27
shortened EF1a promoter rather than the Pgk promoter. Because some Cas9-negative cells 28 accumulated during the course of the experiment, the final blasticidin-selected and unselected cells 29
were FACS-sorted for BFP-positive cells bearing Cas9. 30
25
To process cell samples for sgRNA sequencing, genomic DNA was first isolated using a 1
QiaAmp DNA Blood Maxi kit or QiaAmp DNA mini kit (Qiagen) depending on the scale of the 2 screen batch. Genomic DNA was then amplified using Herculase II polymerase (Agilent) as 3 described 17 , first using outer primers to amplify the sgRNA cassette from nearly all genomic DNA 4 recovered, then inner primers to amplify a portion of the initial PCR product while introducing 5 sample barcodes and adapters for Illumina sequencing (Supplementary Table 9 ). Gel purified PCR 6 products were quantified by Qubit 2.0 fluorometer (Thermo Fisher) using the dsDNA HS kit 7 (Thermo Fisher) and pooled for sequencing. Deep sequencing was performed on a NextSeq 500 8 sequencer with high-output v2 kits (Illumina) to obtain an approximately 500-fold excess of reads 9
to sgRNA library elements. Sequencing was performed using custom primers to read the sgRNA 10 protospacer and sample barcode. 
Immunofluorescence and localization studies 26
For localization studies, IMCD3 FlpIn or 3T3-[Shh-BlastR;Cas9] cells were first plated on 27 acid-washed 13mm round #1.5 coverslips (additionally coated with poly-L-lysine for NIH-3T3 28 cells). After 24 h, cells were transfected with siRNAs (see Supplementary Table 9 for sequences) 29
using Lipofectamine RNAiMAX (Thermo Fisher) or with plasmids using Fugene 6 (Promega). 30
Cells were serum starved for 24 h if needed and then fixed using 4% paraformaldehyde, ice-cold 31 methanol, or both in succession. For GLI2/GLI3/SMO trafficking assays, cells were serum-1 starved for 20 h, followed by 5-6 h incubation in the presence or absence of the appropriate amount 2 of ShhN-conditioned medium. For analysis of TED2-LAP localization, cells were pre-extracted 3 prior to methanol fixation via a one-minute exposure to PHEM buffer (60 mM PIPES, 25 mM 4 HEPES, 4 mM MgSO4, 10 mM EGTA, pH 7.0) with 0.2% TritonX-100. 5
Fixed coverslips were blocked using PBS with 5% BSA and 5% normal donkey serum, 6
permeabilized if needed using PBS with 0.1% Triton X-100, and then incubated with appropriate 7 primary and secondary antibodies (see Supplementary Table 8 for primary antibodies used). 8
Coverslips were then either stained with Hoechst DNA dye, and mounted on slides using 9
Fluoromount-G mounting medium (Electron Microscopy Sciences), or directly mounted using 10
ProLong Gold antifade reagent with DAPI (Life Technologies). 11
Coverslips were imaged at 60x or 63x magnification using one of three microscope systems: 
Western blotting 30
For signaling assays, 3T3-[Shh-BlastR;Cas9] cells transduced with gRNAs as indicated 1 were seeded in a 24-well plate and grown until confluency. Growth medium was then replaced 2 with serum starvation medium with or without ShhN conditioned medium at the appropriate 3 dilution. After 24 h, cells were lysed in SDS sample buffer (50 mM Tris HCl pH 6.8, 8% v/v 4 glycerol, 2% w/v SDS, 100 mM DTT, 0.1 mg/mL bromophenol blue), boiled and sonicated. 5
Samples were loaded onto a 4-15% Criterion TGX Stainfree gel (Bio-Rad), and run for 25 min, 6 300V in Tris/Glycine/SDS buffer (Bio-Rad), before being transferred onto a PVDF membrane 7 using a Transblot Turbo system (Bio-Rad). Membranes were blocked in 1:1 PBS:SeaBlock 8 (Thermo Scientific) for 1 h at room temperature, and subsequently incubated with the indicated 9 primary antibody for 16 h at 4 °C (primary antibodies to GLI1, GLI2, GLI3, SUFU, and importin-10 b, as described in Supplementary Table 8 ). Membranes were washed, incubated with HRP-11 conjugated secondary antibody, washed again, developed using Supersignal West Femto 12
Maximum Sensitivity Substrate (Thermo Fisher) and imaged on a ChemiDoc MP (Bio-Rad). 13
Membranes were stripped using Restore Western Blot stripping buffer (Thermo-Fisher) and re-14 probed as described above. 15
For analysis of immunoprecipitations, Western blotting was performed as described above, 16 except samples were separated in 4-12% Bis-Tris PAGE gels (Invitrogen) using MOPS running 17 buffer, transferred to PVDF membranes using the Criterion Blotter system (Bio-Rad), developed 18 using ECL or ECL 2 chemiluminescence detection kits (Pierce), and imaged on a Chemidoc Touch 19 system (Bio-Rad). 20
21
Large-scale affinity purification and mass spectrometry 22
Affinity purifications were conducted as described 69 . Briefly, approximately 500-1000 µl 23 packed cell volume was lysed in LAP purification buffer containing 0.3% NP-40. Lysate was 24 cleared sequentially at 16,000 x g and 100,000 x g before incubation with anti-GFP antibody 25 coupled to Protein A resin. After protein capture and washes, bound LAP-tagged proteins were 26 eluted by incubation with HRV3C protease. For mass spectrometry analysis 'A' (see 27 Supplementary Table 6 ), eluted proteins were further purified by capture on S-Protein agarose 28
followed by elution at 95°C in lithium dodecyl sulfate-based gel loading buffer. For protein analysis by mass spectrometry, gel slices containing affinity-purified proteins 30
were washed with 50 mM ammonium bicarbonate, followed by reduction with DTT (5 mM) and 31 alkylation using propionamide (10 mM). Gel slices were further washed with an acetonitrile-1 ammonium bicarbonate buffer until all stain was removed. 120 ng of Trypsin/LysC (Promega) 2 reconstituted in 0.1% ProteaseMAX (Promega) with 50 mM ammonium bicarbonate was added 3 to each gel band; after 30 min ~20 µL of additional 50 mM ammonium bicarbonate in 0.1% 4
ProteaseMAX was added. Digestion was then allowed to occur overnight at 37 °C. Peptides were 5 extracted from the gels in duplicate followed by drying using a SpeedVac concentrator. Peptide 6 pools were then reconstituted and injected onto a C18 reversed phase analytical column, ~20 cm 7 in length, pulled and packed in-house. The UPLC was a NanoAcquity or M-Class column 8 (Waters), operated at 450 nL/min using a linear gradient from 4% mobile phase B to 45% B. 9
Mobile phase A consisted of 0.2% formic acid, water, Mobile phase B was 0.2% acetic acid, 10 acetonitrile. The mass spectrometer was an Orbitrap Elite or Fusion (Thermo Fisher) set to acquire 11 in a data-dependent fashion selecting and fragmenting the 15 most intense precursor ions in the 12 ion-trap, where the exclusion window was set at 45 seconds and multiple charge states of the same 13 ion were allowed. 14
15
QUANTIFICATION AND STATISTICAL ANALYSIS 16
Analysis of CRISPR-based screens 17
CRISPR-based screens were analyzed as described 27 , processing data from each screen 18 batch separately. Briefly, to determine sgRNA counts in each sample, raw sequencing reads were 19 trimmed to the 3'-most 17 nt of each protospacer and aligned to expected sgRNA sequences. This 20 alignment was carried out with the makeCounts script of the casTLE software package, which uses 21 Bowtie 73 to perform alignment with zero mismatches tolerated. The analyzeCounts script (v0.7 22 and v1.0) of the casTLE software available at https://bitbucket.org/dmorgens/castle 27 was then 23 used to identify genes exhibiting significant enrichment or depletion and to estimate the phenotypic 24 effect size for each gene. This method uses an empirical Bayesian approach to score genes 25 according to the log-likelihood ratio that a gene's observed changes in sgRNA counts is drawn 26 from a model of gene effect versus the distribution of negative control sgRNAs. An expected 27 negative score distribution is obtained by random permutation of gene-targeting sgRNA fold-28 change values and used to determine a P value for each gene. Note that the use of 100,000 29 permutations leads to a minimum reported P value of 1 x 10 -5 . 30
29
Genes targeted by our sgRNA library that lacked an NCBI identifier or that severely 1 affected growth (casTLE effect size ≤ -2.5 and casTLE P value < 0.005) were not considered for 2 further analysis but are included in Supplementary Table 3 . Negative and positive reference genes 3 were defined for growth and signaling phenotypes based on gene sets previously defined by Hart 4 et al. 28 and Roosing et al. 9 , respectively (Supplementary Table 3 ). Precision-recall and ROC curves 5 using these reference genes were computed in Matlab (Mathworks). The hit genes at 10% and 20% 6 false discovery rate cutoffs were defined using the precision-recall threshold values at precision of 7 0.9 and 0.8, yielding P value cutoffs of 0.0163 and 0.0338, respectively. Ciliopathy-associated 8 genes were defined from the OMIM website. Functional category enrichment analysis for hit genes 9
in the 10% FDR category was performed using the DAVID website's Functional Annotation Chart 10 tool using all mouse genes as the background 29 . A second analysis was also performed using human 11 homologs of the top hits using all human genes as the background. Significance of overlap between 12 the top 15 congenital heart defect genes reported by Sifrim et al. 49 and P values from functional 13 screening was assessed using the Kolmogorov-Smirnov test. 14
15
Quantification of Hh signaling assays 16
Blasticidin-based inhibition of cell growth was determined by normalizing raw CellTiter-17
Blue fluorescence such that growth in the absence of blasticidin corresponds to 100% growth while 18 medium alone corresponds to 0% growth. The IC50 for blasticidin was determined using Prism 7.0 19 (Graphpad Software) to fit dose-response data to log(inhibitor) versus response with variable slope. 20
Data shown are average of two to five independent assays conducted in duplicate for each 21 condition and cell line. images before analysis. To determine ciliary frequency, cells were manually scored for the presence 1 or absence of a cilium using ARL13B and acetylated tubulin as ciliary markers. For ciliary length 2 and intensity of ciliary markers analyses, the ARL13B and/or acetylated tubulin channels were 3 used to create a ciliary mask and to measure cilium length. The ciliary mask was then used to 4 identify and measure ciliary signal in the other channels. The γ-tubulin or ninein signal (staining 5 centrioles) was used to orient all cilia from base to tip. Tip fluorescence for GLI2 and GLI3 was 6 defined as the summed fluorescence in the final five pixels of each cilium, regardless of length. For 7 ARMC9-FLAG localization, the ciliary fluorescence of each individual cilium was normalized to 8 1, and each axoneme divided in 20 equal distance bins. The fraction of FLAG signal within each 9
bin is plotted for N>500 cilia from one out of three representative experiments. Where indicated 10 in the Figure Legend , data is shown relative to values obtained for the control sgRNA using Prism 11 7 (GraphPad Software). 12
Differences in cilium length distribution were tested for significance using the Smirnov test in Matlab. Line plots of fluorescence intensity along cilia were generated in ImageJ. Uniprot for Mus musculus downloaded on 10/25/2016. These data were validated at a 1% false 29 discovery rate using typical reverse-decoy techniques 74 . The resulting identified peptide spectral 30 31 matches and assigned proteins were then exported for further analysis using MatLab (MathWorks) 1 to provide visualization and statistical characterization. 
Analysis of CRISPR growth screen datasets 4
Gene-level growth phenotype data 61 were downloaded from the Achilles website. 5
Hierarchical clustering using uncentered correlation and average linkage settings was performed 6
using Cluster 3.0 software 75 , and clustered data were visualized in Java Treeview 76 . 7 8
Phylogenetic analysis 9
Homologs for Tubd1 and Tube1 were either previously described 64 or identified using 10 protein BLAST. Homologs for Ted1 and Ted2 were identified using iterative searches with PSI-11 BLAST 77 . To analyze sequence divergence, homolog sequences were first aligned using Clustal 12 Omega 78 . Phylogenetic trees were generated via neighbor joining with distance correction using 13
Simple Phylogeny 78 and visualized using Unrooted 79 . 14
15
DATA AND SOFTWARE AVAILABILITY 16
Data resources including aligned sgRNA sequences, screen sequencing data, casTLE 17 output, positive and negative reference gene sets for growth and ciliary signaling phenotypes, 18 functional categories enriched among hit genes, phylogenetic analysis of TED complex 19 components, and mass spectrometry-based protein identifications can be found in Supplementary  20   Tables 2, 3 , 5, and 6. Software used for casTLE analysis can be found at 21 http://bitbucket.org/dmorgens/castle. Scripts for quantification of cilium intensities and length 22 are available upon request. 23 detection for select gene categories, with the fraction of hits detected at 10% or 20% FDR, not 4 detected, or not determined shown; see Supplementary Table 3 for details. The NPHP category 5
Figure Legends
includes genes mutated exclusively in NPHP and not other ciliopathies. Abbreviations: SRTD 6 (short rib thoracic dysplasia), JATD (Jeune asphyxiating thoracic dysplasia), OFD (Oral-Facial-7
Digital Syndrome). c) Hit gene identification is compared for the indicated datasets. Pie charts 8
show the fraction of genes detected as hits across all genes included in part (b), except the NPHP-9 specific category; see Supplementary Figure 4 for detail among individual categories. shows mean and standard deviation (three independent experiments, >700 cells counted total). 19
Scale bars: 5 µm (upper images) and 1 µm (lower images). See also Supplementary Figure 5a showing localization relative to centrioles, marked by ninein, and the cilium, marked by ARL13B. 27
Scale bar: 1 µm. e) Plots of ARMC-FLAG intensity along the length of the cilium from base 28 (position 0) to tip (position 1.0) are shown for IMCD3 cells treated as indicated. The mean and 29 standard deviation are plotted after normalizing the total intensity in each cilium to 1.0 (N > 500 30 cilia, representative example from 3 independent experiments). f) Fluorescence intensity of GLI3 31 at the cilium tip was measured for the indicated cells in the presence or absence of ShhN. Mean 1 intensity (relative to control sgRNA cells +ShhN) and standard error of the mean are shown for 2 each of three experiments (N > 250 cilia in each experiment). See also Supplementary Fig. 5d . g) 3 Table showing select γ-tubulin were counted in cells at the indicated cell cycle stages, with each cell categorized as having 29 either zero centrioles, some centrioles but fewer than expected for that stage in the cell cycle (two 30 or four), the expected two or four centrioles, or more than the expected number of centrioles. 31 
